n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with lj 529 in 5 studies
Studies (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Trials (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Recent Studies (post-2010) (n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine) | Studies (lj 529) | Trials (lj 529) | Recent Studies (post-2010) (lj 529) |
---|---|---|---|---|---|
214 | 5 | 58 | 12 | 0 | 3 |
Protein | Taxonomy | n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50) | lj 529 (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 0.0006 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chun, MW; Gao, ZG; Gunaga, P; Jacobson, KA; Jeong, LS; Jin, DZ; Kim, HO; Kim, YC; Melman, N; Moon, HR; Shin, DH | 1 |
Choe, SA; Choi, WJ; Gao, ZG; Hou, X; Jacobson, KA; Jeong, LS; Kim, HO; Klutz, AM; Lee, HW; Lee, SK; Moon, HR; Pal, S; Tosh, DK | 1 |
Chinn, M; Choi, WJ; Gao, ZG; Jacobson, KA; Jeong, LS; Jung, YH; Kim, HO; Lee, HW; Moon, HR; Patel, A | 1 |
Ahn, S; Cheong, JH; Jacobson, KA; Jeong, LS; Jin, SH; Kim, G; Kim, HJ; Kim, J; Lee, E; Lee, M; Noh, M; Yu, J | 1 |
Ahn, S; An, S; Choi, H; Jeong, LS; Ko, H; Noh, M; Pyo, JJ; Shin, JC; Yu, J | 1 |
5 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and lj 529
Article | Year |
---|---|
N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.
Topics: Adenosine; Animals; Cerebral Cortex; CHO Cells; Corpus Striatum; Cricetinae; Humans; Ligands; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Structure-Activity Relationship; Thionucleosides | 2003 |
Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Humans; Molecular Structure; Rats; Receptor, Adenosine A3; Structure-Activity Relationship; Thionucleosides | 2008 |
Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.
Topics: Adenosine A3 Receptor Agonists; Amides; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Kinetics; Magnetic Resonance Spectroscopy; Radioligand Assay; Spectrometry, Mass, Fast Atom Bombardment; Thionucleosides | 2009 |
Polypharmacology of N
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adiponectin; Animals; Cell Line; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Male; Mice; Mice, Inbred C57BL; Polypharmacology; PPAR delta; PPAR gamma; Receptor, Adenosine A3 | 2017 |
Selenium bioisosteric replacement of adenosine derivatives promoting adiponectin secretion increases the binding affinity to peroxisome proliferator-activated receptor δ.
Topics: Adenosine; Adiponectin; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mesenchymal Stem Cells; Molecular Docking Simulation; Molecular Structure; PPAR delta; Selenium; Structure-Activity Relationship | 2020 |